Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lisdexamfetamine for cocaine dependence
NCT00958282Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Jul 2009
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cocaine dependence comparing lisdexamfetamine/Behavior Therapy with placebo (2 arms). Primary endpoint: Cocaine-positive Urine Results at 14 weeks. Started Jul 2009; status: completed.
02
Drugs
lisdexamfetamine
03
Conditions
cocaine dependence
Beyond the preview
Go deeper on NCT00958282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00958282.